Catalyst Wire Dossier Catalyst Wire Dossier
FDA label_change · 2015-10-09

FDA Approved: ONDANSETRON — Supplemental Application (Fresenius Kabi USA, LLC)

View source ↗

Summary

FDA approved a supplemental application for ondansetron hydrochloride from Fresenius Kabi USA, LLC (ANDA202253), typically involving labeling or formulation upd…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ondansetron (ondansetron)

Snippet

SUPPL AP for ONDANSETRON (ONDANSETRON HYDROCHLORIDE)